Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Nov 13, 2023 12:07pm
128 Views
Post# 35732117

Pfizer, weight loss market, $90 billion estimated by Pfizer

Pfizer, weight loss market, $90 billion estimated by PfizerBlueberry indica strain worked wonders for me, I lost 40 to 45 pounds of useless, joint straining, fat.   You formulate to address obesity specifically with a combination of cannabinoid compounds and suddenly you become a player in that $90 billion segment.   A big new juicy lollipop for big pharma.  

Pidduck...why so quiet on the new technology transfer regarding SEDDS technology from Avicanna?  

Maybe you need to own more of LABS, a wonderful leading indicator of what this company is really worth along with ITG Virtu group milking out as many as shares as possible.  

Titrate it way up for those bigger bonuses...oh apologies that was for opiates and fentanyl based killer drugs.  
<< Previous
Bullboard Posts
Next >>